Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice

Kowalewski B, Lamanna WC, Lawrence R, Damme M, Padva M, Stroobants S, Kalus I, Frese M-A, Lübke T, Lüllmann-Rauch R, D'Hooge R, et al. (2012)
Proc. Natl. Acad. Sci. USA 109(26): 10310-10315.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ; ;
Alle
Erscheinungsjahr
Zeitschriftentitel
Proc. Natl. Acad. Sci. USA
Band
109
Zeitschriftennummer
26
Seite
10310-10315
ISSN
eISSN
PUB-ID

Zitieren

Kowalewski B, Lamanna WC, Lawrence R, et al. Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA. 2012;109(26):10310-10315.
Kowalewski, B., Lamanna, W. C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., et al. (2012). Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA, 109(26), 10310-10315. doi:10.1073/pnas.1202071109
Kowalewski, B., Lamanna, W. C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., Frese, M. - A., Lübke, T., Lüllmann-Rauch, R., et al. (2012). Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA 109, 10310-10315.
Kowalewski, B., et al., 2012. Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA, 109(26), p 10310-10315.
B. Kowalewski, et al., “Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice”, Proc. Natl. Acad. Sci. USA, vol. 109, 2012, pp. 10310-10315.
Kowalewski, B., Lamanna, W.C., Lawrence, R., Damme, M., Padva, M., Stroobants, S., Kalus, I., Frese, M.-A., Lübke, T., Lüllmann-Rauch, R., D'Hooge, R., Esko, J.D., Dierks, T.: Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice. Proc. Natl. Acad. Sci. USA. 109, 10310-10315 (2012).
Kowalewski, Björn, Lamanna, William Christopher, Lawrence, Roger, Damme, Markus, Padva, Michael, Stroobants, Stijn, Kalus, Ina, Frese, Marc-André, Lübke, Torben, Lüllmann-Rauch, Renate, D'Hooge, Rudi, Esko, Jeffrey D, and Dierks, Thomas. “Arylsulfatase G Inactivation Causes Loss of Heparan Sulfate 3-O-Sulfatase Activity and Mucopolysaccharidosis in Mice”. Proc. Natl. Acad. Sci. USA 109.26 (2012): 10310-10315.

21 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical Usher syndrome in humans.
Khateb S, Kowalewski B, Bedoni N, Damme M, Pollack N, Saada A, Obolensky A, Ben-Yosef T, Gross M, Dierks T, Banin E, Rivolta C, Sharon D., Genet Med (), 2018
PMID: 29300381
Genetics and pathophysiology of mammalian sulfate biology.
Langford R, Hurrion E, Dawson PA., J Genet Genomics 44(1), 2017
PMID: 28063738
The function of heparan sulfate during branching morphogenesis.
Patel VN, Pineda DL, Hoffman MP., Matrix Biol 57-58(), 2017
PMID: 27609403
Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice.
Dwyer CA, Scudder SL, Lin Y, Dozier LE, Phan D, Allen NJ, Patrick GN, Esko JD., Sci Rep 7(), 2017
PMID: 28418018
GM2 Gangliosidosis in Shiba Inu Dogs with an In-Frame Deletion in HEXB.
Kolicheski A, Johnson GS, Villani NA, O'Brien DP, Mhlanga-Mutangadura T, Wenger DA, Mikoloski K, Eagleson JS, Taylor JF, Schnabel RD, Katz ML., J Vet Intern Med 31(5), 2017
PMID: 28833537
The Chihuahua dog: A new animal model for neuronal ceroid lipofuscinosis CLN7 disease?
Faller KM, Bras J, Sharpe SJ, Anderson GW, Darwent L, Kun-Rodrigues C, Alroy J, Penderis J, Mole SE, Gutierrez-Quintana R, Guerreiro RJ., J Neurosci Res 94(4), 2016
PMID: 26762174
From bedside to cell biology: a century of history on lysosomal dysfunction.
Coutinho MF, Matos L, Alves S., Gene 555(1), 2015
PMID: 25275857
Ataxia is the major neuropathological finding in arylsulfatase G-deficient mice: similarities and dissimilarities to Sanfilippo disease (mucopolysaccharidosis type III).
Kowalewski B, Heimann P, Ortkras T, Lüllmann-Rauch R, Sawada T, Walkley SU, Dierks T, Damme M., Hum Mol Genet 24(7), 2015
PMID: 25452429
Sanfilippo syndrome: causes, consequences, and treatments.
Fedele AO., Appl Clin Genet 8(), 2015
PMID: 26648750
Glycan-based biomarkers for mucopolysaccharidoses.
Lawrence R, Brown JR, Lorey F, Dickson PI, Crawford BE, Esko JD., Mol Genet Metab 111(2), 2014
PMID: 23958290
Heparan sulfate 3-O-sulfation: a rare modification in search of a function.
Thacker BE, Xu D, Lawrence R, Esko JD., Matrix Biol 35(), 2014
PMID: 24361527
Genome-wide association study in musician's dystonia: a risk variant at the arylsulfatase G locus?
Lohmann K, Schmidt A, Schillert A, Winkler S, Albanese A, Baas F, Bentivoglio AR, Borngräber F, Brüggemann N, Defazio G, Del Sorbo F, Deuschl G, Edwards MJ, Gasser T, Gómez-Garre P, Graf J, Groen JL, Grünewald A, Hagenah J, Hemmelmann C, Jabusch HC, Kaji R, Kasten M, Kawakami H, Kostic VS, Liguori M, Mir P, Münchau A, Ricchiuti F, Schreiber S, Siegesmund K, Svetel M, Tijssen MA, Valente EM, Westenberger A, Zeuner KE, Zittel S, Altenmüller E, Ziegler A, Klein C., Mov Disord 29(7), 2014
PMID: 24375517
A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.
Guo J, O'Brien DP, Mhlanga-Mutangadura T, Olby NJ, Taylor JF, Schnabel RD, Katz ML, Johnson GS., BMC Vet Res 10(), 2014
PMID: 25551667
Lysosomal diseases: diagnostic update.
Winchester B., J Inherit Metab Dis 37(4), 2014
PMID: 24711203
Hs3st3-modified heparan sulfate controls KIT+ progenitor expansion by regulating 3-O-sulfotransferases.
Patel VN, Lombaert IM, Cowherd SN, Shworak NW, Xu Y, Liu J, Hoffman MP., Dev Cell 29(6), 2014
PMID: 24960693
The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape.
Bodamer OA, Giugliani R, Wood T., Mol Genet Metab 113(1-2), 2014
PMID: 25127543
Molecular characterization of arylsulfatase G: expression, processing, glycosylation, transport, and activity.
Kowalewski B, Lübke T, Kollmann K, Braulke T, Reinheckel T, Dierks T, Damme M., J Biol Chem 289(40), 2014
PMID: 25135642
Development of cerebellar pathology in the canine model of mucopolysaccharidosis type IIIA (MPS IIIA).
Hassiotis S, Jolly RD, Hemsley KM., Mol Genet Metab 113(4), 2014
PMID: 25453402
Molecular characterization of 355 mucopolysaccharidosis patients reveals 104 novel mutations.
Pollard LM, Jones JR, Wood TC., J Inherit Metab Dis 36(2), 2013
PMID: 22976768
Arylsulfatase K, a novel lysosomal sulfatase.
Wiegmann EM, Westendorf E, Kalus I, Pringle TH, Lübke T, Dierks T., J Biol Chem 288(42), 2013
PMID: 23986440

33 References

Daten bereitgestellt von Europe PubMed Central.

Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alpha-mannosidosis.
D'Hooge R, Lullmann-Rauch R, Beckers T, Balschun D, Schwake M, Reiss K, von Figura K, Saftig P., J. Neurosci. 25(28), 2005
PMID: 16014715
Molecular characterization and gene disruption of mouse lysosomal putative serine carboxypeptidase 1.
Kollmann K, Damme M, Deuschl F, Kahle J, D'Hooge R, Lullmann-Rauch R, Lubke T., FEBS J. 276(5), 2009
PMID: 19187242
Conversion of cysteine to formylglycine: a protein modification in the endoplasmic reticulum.
Dierks T, Schmidt B, von Figura K., Proc. Natl. Acad. Sci. U.S.A. 94(22), 1997
PMID: 9342345
Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine.
Lundquist P, Martensson J, Sorbo B, Ohman S., Clin. Chem. 26(8), 1980
PMID: 7389089
[Effect of the injection of Triton WR 1339 on the hepatic lysosomes of the rat.]
WATTIAUX R, WIBO M, BAUDHUIN P., Arch. Int. Physiol. Biochim. 71(), 1963
PMID: 13999241
Special considerations for proteoglycans and glycosaminoglycans and their purification
Esko JD., 2001
Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.
Lawrence R, Olson SK, Steele RE, Wang L, Warrior R, Cummings RD, Esko JD., J. Biol. Chem. 283(48), 2008
PMID: 18818196

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 22689975
PubMed | Europe PMC

Suchen in

Google Scholar